Advertisement

Topics

Trump Executive Order Draft On Drug Prices Would Decrease Regulations, Take Steps To Increase Competition

09:34 EDT 23 Jun 2017 | Kaiser Health News

CQ Roll Call reports that a draft document indicates that the Trump administration leaning toward a roll back of regulations to foster faster drug approvals and promoting competition and new payment models for federal insurance programs. In other pharmaceutical industry news, Mylan shareholders reject the EpiPen maker's executive pay policy but re-elect its board.

Original Article: Trump Executive Order Draft On Drug Prices Would Decrease Regulations, Take Steps To Increase Competition

NEXT ARTICLE

More From BioPortfolio on "Trump Executive Order Draft On Drug Prices Would Decrease Regulations, Take Steps To Increase Competition"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...